The hexane extract from the leaves of Canella winterana exhibited strong activity against the chloroquine sensitive (CQS) strain of Plasmodium falciparum (D10) in vitro (IC 50 2.53 µg/mL). Bioassay guided fractionation of this extract has led to the isolation of 5 drimane-type sesquiterpenoids: 9-epideoxymuzigadial, 9-deoxymuzigadial, muzigadial, 3-β-acetoxypolygodial and the newly isolated hemiacetal, named muzigodiol, with IC 50 -values of 1.01, 2.19, 0.31, 2.77 and 7.43 µg/mL, respectively.
Malaria is one of the most important health problems in tropical and subtropical regions of the world [1a] . One of the main factors contributing to the escalating prevalence and distribution of malaria is the emergence and spread of drug-resistant parasites highlighting a need for the discovery and development of novel, affordable antimalarial treatments.
Drug discovery based on results from in vitro antiplasmodial bioassays, i.e., bioassay-guided isolation, has revealed many active constituents from plant origins [1b] . Canella is one of five genera (Canella, Cinnamosa, Pleodendron, Warburgia and Capsicocordendron or Cinnamodendron) of the family Canellaceae. All plants belonging to this family are characterized by their high content of drimane-type sesquiterpenoid dialdehydes, which are considered chemosystematic markers of the Canellaceae [1c]. One of the species belonging to this family, Cinnamosma fragrans Baill, is traditionally used in the east and central parts of Madagascar for the treatment of malaria symptoms [2] As a part of a large project seeking new antimalarial lead compounds, we investigated the antiplasmodial activity of Canella winterana (L.) Gaertin leaves. C.
winterana is a small tree that grows in the subtropical areas of the Florida Keys, and throughout the Caribbean region. The bark is used as a spice similar to true cinnamon, giving rise to the common name "wild cinnamon" [3] . The plant is known as a rich source of drimane sesquiterpenoids with unsaturated 1, 4-dialdehyde functionality. Most of these compounds have a very hot taste and are known for their antifeedant [4a] , molluscicidal [4b] and antimicrobial activities [4c]. Several drimane sesquiterpene compounds have been reported for this plant [5a-5c] . C. winterana was originally screened by Spencer and co-workers during the World War II era [6a] in an effort to identify candidates with antimalarial activity. Their results showed that water extracts from stems showed very high quinine equivalent activity when administered orally to Plasmodium gallinaceum sporozoite infected chicks. However, further characterization of the active principles was not conducted.
In order to determine the antiplasmodial principles in C. winterana leaves, we followed an isolation scheme which, at every step, monitored and assessed the antiplasmodial activity of the resulting fractions. Dried powdered leaves were extracted sequentially with n-hexane, ethyl acetate and methanol. The n-hexane and ethyl acetate extracts were found to be active with IC 50 values of 2.53 and 5.30 µg/mL, respectively. HPLC and TLC of both n-hexane and ethyl acetate extracts indicated close similarity of their main components (data not shown). The n-hexane extract was subjected to further fractionation, which led to the isolation of five structurally related compounds of the drimane sesquiterpene class of compounds (1-5, Figure 1 ).
Compounds 1 and 2 were identified as 9-epideoxymuzigadial and its stereoisomer, 9-deoxymuzigadial, respectively. Both compounds have been previously reported for C. winterana [5b,5c]. Compound 3, which represented the major compound in the n-hexane extract (~ 8.5%), was identified as muzigadial. Muzigadial was first isolated from Warburgia ugandensis [4a] , and then from C. winterana and fully identified through X-ray crystallography and given another name "canellal" [5a] . Compound 4 was identified as 3β-acetoxypolygodial [5c]. Although compounds 1-4 have been previously reported in C. winterana for their antimicrobial and phytotoxic properties [5a,6b] , this is the first report to assign their antiplasmodial activity. Compound 5 was purified by repeated TLC to afford white crystalline material. The 1 H and 13 C NMR spectra, unlike compounds 1-4, lacked the downfield signals for the aldehydic functionality. This led us to suspect cyclization to form the hemiacetal. The study of the 1 H, 13 C, COSY, NOSEY, HMQC and HMBC NMR spectra and with the aid of the HR MS, 5 was identified as the hemiacetal derivative of muzigadial and given the name muzigodiol (5, Figure 1 ). This is the first time that this compound has been isolated from either C. winterana or any other natural resource. The hemiacetal of muzigadial was previously prepared by fermentation of muzigadial with certain microbial cultures. In the same study, the same compound was prepared synthetically by the reaction of muzigadial with diisobutylaluminum hydride [6c].
Although the acetals are reported as natural products, they were often considered artifacts. This usually occurs by reactions of bioactive compounds when extracted with alcohols [6d]. Since we did not use methanol for extraction, and the leaves were collected fresh and directly freeze-dried, we confirm that the hemiacetal form is a natural metabolite of this plant.
Results of the in vitro antiplasmodial activity of the five purified sesquiterpenoids 1-5 (Table 1) showed that muzigadial (3) was the most potent sesquiterpene against the chloroquine-sensitive strain of P. falciparum (D10) with an IC 50 -value of 0.31 µg. 9-Deoxymuzigadial (2) and 9-epideoxymuzigadial (1) showed antiplasmodial activity of 2.19 and 1.01 µg/mL, respectively. Comparing the structures of compounds 1-3 (Figure 1 ), we could see that muzigadial (3) has an additional hydroxyl group at position 9. This indicated that the hydroxyl substitution at this position increased the antiplasmodial activity of muzigadial by about 7 and 3 fold compared with its deoxy compounds 1 & 2, respectively. Muzigadial has been reported as one of the strongest antimicrobial drimane sesquiterpenes isolated from the Warburgia genus [4c].
Interestingly, it was found that 9-epideoxymuzigadial (1) showed higher activity than its isomer 9-deoxymuzigadial (2) (~2 fold), indicating that the α-orientation of the aldehyde group in 9-deoxy drimane sesquiterpenes is favorable for antiplasmodial activity. 3β-Acetoxypolygodial (4) showed antiplasmodial activity with an IC 50 of 2.77 µg/mL which is comparable with 9-deoxymuzigadial (IC 50 2.19 µg/mL). Compound 4 has the same configuration of the aldehydic groups as compound 2, but they differ in ring A methyl group arrangement, and the β-acetoxy substitution at C-3 (see Figure 1 ), which indicated that the substitution and arrangement of positions 3 and 4 in ring A did not affect the antiplasmodial activity. This finding supports the reported literature for the phytotoxic activity of sesquiterpenes from C. winterana [6b].
Muzigodiol (5), the hemiacetal cyclic form of muzigadial was the least active antiplasmodial compound with an IC 50 of 7.43 µg/mL. The diminished activity compared with muzigadial indicated the importance of the 1, 4 dialdehydic groups for the Bioactive drimane sesquiterpenes from Canella winterana Natural Product Communications Vol. 5 (12) 2010 1871 antiplasmodial activity. This finding was different from the published results for the phytotoxic activity of sesquiterpenes from C. winterana, where they found that compounds with masked aldehydic groups still retained the tested activity [6b].
The isolated sesquiterpenes 1-5 were also tested for cytotoxicity to test their selective antiplasmodial activity reflected by their selectivity index (IC 50 CHO/ IC 50 D10) (see Table 1 ). Muzigadial showed a high cytotoxicity (IC 50 1.18 µg/mL, SI 3.8), indicating nonspecific activity. Interestingly, the 9-deoxymuzigadial (2) was much less toxic than its stereoisomer 9-epideoxymuzigadial (1) (IC 50 33.96 and 1.82 µg/mL, SI 15.5 and 1.8, respectively). 3-β-Acetoxypolygodial (4) was the least toxic compound to the CHO cells (IC 50 58.31 µg/mL, SI 20.7), indicating that the 3β-acetoxy substitution with 4 dimethyl arrangement has a significant effect in reducing the toxicity of this dialdehyde sesquiterpene.
The stereochemistry and the presence of a substituent may modulate the reactivity and bioactivity of the unsaturated dialdehydes considerably. It was reported that polygodial, a drimane sesquiterpene analogous to 9-deoxymuzigadial with 4 dimethyl groups, is known to react with primary amines under biomimetic conditions to form pyrroles, a reaction that has been proposed to be responsible for the bioactivity of polygodial. It was found that its 9-epimer was less bioactive, and did not undergo the same reaction because the formation of a pyrrole is less favored due to the larger distance between the aldehyde carbons [7a] .
We conclude that the presence of these very reactive compounds is responsible for the biological activities of this plant and related plants containing the same type of compounds. The major component identified in this plant was muzigadial (3). Although muzigadial showed very strong in vitro antiplasmodial activity, its potential for development as an antimalarial drug is limited due to its inherent cytotoxicity and lack of selectivity. This is often the case with antimalarial compounds identified from plants [1b]. 9-Deoxymuzigadial (2) and 3β-acetoxypolygodial (4) showed less antiplasmodial activity than muzigadial, but they were less toxic to the CHO cells. The three compounds (2) (3) (4) represent hits that could potentially be subjected to more detailed analysis. These compounds could also be used as scaffolds to generate leads with enhanced antiplasmodial activity, reduced cytotoxicity and improved bioavailability using different medicinal chemistry approaches to the dialdehyde reactive sites of the molecule.
Experimental
Plant material: Leaves from C. winterana were collected from Coral Gables, Fairchild Tropical Botanical Garden, Florida in October 2008 and identified by Dr Lena Struwe (Rutgers University). A voucher specimen (RG # 6) was deposited in the Chrysler Herbarium (CHRB) at Rutgers University, New Brunswick, NJ. The leaves were freeze-dried and stored at room temperature until extraction.
Extraction and bioassay-guided fractionation:
Dried powdered leaves (200 g) were successively extracted with n-hexane (3 X 1L), ethyl acetate (3 x 1L) and methanol (3 x 1L) at room temperature. The solvents were evaporated to afford 13.4 g, 4.75 g and 17.5 g, respectively. The n-hexane extract (11.5 g) was subjected to flash chromatography using silica gel G 60 (Merck, 70-230 mesh, 2.5 x 30 cm). Gradient elution was performed using n-hexane with increasing amounts of ethyl acetate from 10 to 100%. Twelve fractions, 500 mL each, were collected and bioassayed for their antiplasmodial activity. Active fractions were subjected to further fractionation using flash chromatography and elution with varying solvent gradients of n-hexane-ethyl acetate. Separation was monitored by TLC (benzeneethyl acetate 8:2, visualization with vanillin/H 2 SO 4 ), as well as HPLC-UV. Fractionation was guided by antiplasmodial testing to concentrate on isolating and purifying only compounds which showed activity. Fraction 2 (5.13 g), eluted with 20% ethyl acetate in n-hexane, was further fractionated to afford 9-epideoxymuzigadial (1, 120 mg) [5c] and 9-deoxymuzigadial (2, 200 mg) [5b] . Fraction 3 (0.5 g), eluted with 30% ethyl acetate in n-hexane was further fractionated using CC and crystallization (diethyl ether) to afford another quantity of 9-deoxymuzigadial (2, 150 mg), muzigadial (3, 90 mg) [5c] and 3β-acetoxypolygodial (4, 150 mg ) [5c] in pure form. Fraction 4 (2.4 g) was subjected to crystallization from n-hexane-diethyl ether. Crystals were washed with ice cold diethyl ether to afford a larger quantity of muzigadial (3, 890 mg In vitro cytotoxicity assay: Active fractions and pure compounds were tested for in vitro cytotoxicity against a Chinese Hamster Ovarian (CHO) cell line using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay [8c]. The CHO cells were cultured in Dulbecos Modified Eagles Medium (DMEM): Hams F-12 medium (1:1) supplemented with 10% heat-inactivated fetal calf serum (FCS) and gentamycin (0.05 µg/mL). Sample preparation was the same as for antiplasmodial testing. The highest concentration of solvent to which the cells were exposed had no measurable effect on cell viability. Emetine dihydrochloride (Sigma) was used as the positive control in all cases. The initial test concentration of emetine was 100 µg/mL, which was serially diluted in complete medium with 10-fold dilutions to give 6 concentrations, the lowest being 0.001 µg/mL. The same dilution technique was applied to all test samples with an initial concentration of 100 µg/mL to give 5 concentrations, with the lowest being 0.01 µg/ mL. The concentration of test samples that inhibited 50% of the cells (IC 50 values) was obtained from dose-response curves, using a non-linear doseresponse curve fitting analyses via GraphPad Prism v. 4 software.
